Scientist removed as director of federal agency working on coronavirus vaccine to file whistleblower complaint

Attorneys for Rick Bright, the federal scientist who once led the department leading coronavirus vaccine development, said on Thursday he is filing a whistleblower complaint, alleging that he was ousted because he did not promote a drug treatment touted by President Trump.
Bright was removed on Tuesday as director of the Biomedical Advanced Research and Development Authority, and given a job at the National Institutes of Health with fewer responsibilities. Bright's lawyers said they will file formal complaints with the inspector general of the Health and Human Services Department and the federal Office of Special Counsel, which will detail "the retaliatory treatment to which he was subjected by HHS political leadership after raising appropriate science-based concerns about White House pressure on treatment and vaccines related to the COVID-19 pandemic."
The filings will also "make clear that Dr. Bright was sidelined for one reason only — because he resisted efforts to provide unfettered access to potentially dangerous drugs, including chloroquine, a drug promoted by the administration as a panacea, but which is untested and possibly deadly when used improperly. The facts and concerns raised by Dr. Bright are compelling and well-documented and soon they will be public."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Bright released a statement on Wednesday saying he believes he was removed as director after he made it known he felt "the billions of dollars allocated by Congress to address the COVID-19 pandemic" should be put "into safe and scientifically vetted solutions, and not in drugs, vaccines, and other technologies that lack scientific merit." When asked about this by reporters, Trump said he had never heard of Bright.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Today's political cartoons - March 8, 2025
Cartoons Saturday's cartoons - trade wars, healthcare costs, and more
By The Week US Published
-
Marbled tea eggs recipe
The Week Recommends With a beautiful exterior, these eggs are also marked by their soft yolk
By The Week UK Published
-
The Washington Post: kowtowing to Trump?
Talking Point The newspaper's opinion editor has handed in his notice following edict from Jeff Bezos
By The Week UK Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published